Whittier Trust Co. of Nevada Inc. Purchases New Position in SPDR S&P Biotech (NYSEARCA:XBI)

Whittier Trust Co. of Nevada Inc. acquired a new position in shares of SPDR S&P Biotech (NYSEARCA:XBI) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 18,079 shares of the exchange traded fund’s stock, valued at approximately $1,586,000.

A number of other large investors have also bought and sold shares of the stock. Brick & Kyle Associates raised its holdings in SPDR S&P Biotech by 6.3% in the fourth quarter. Brick & Kyle Associates now owns 9,673 shares of the exchange traded fund’s stock worth $821,000 after buying an additional 575 shares during the last quarter. Commerzbank Aktiengesellschaft FI raised its holdings in shares of SPDR S&P Biotech by 17.6% during the fourth quarter. Commerzbank Aktiengesellschaft FI now owns 4,594 shares of the exchange traded fund’s stock valued at $390,000 after purchasing an additional 686 shares during the last quarter. Tocqueville Asset Management L.P. raised its holdings in shares of SPDR S&P Biotech by 3.4% during the fourth quarter. Tocqueville Asset Management L.P. now owns 22,640 shares of the exchange traded fund’s stock valued at $1,921,000 after purchasing an additional 750 shares during the last quarter. First Capital Advisors Group LLC. raised its holdings in shares of SPDR S&P Biotech by 19.4% during the fourth quarter. First Capital Advisors Group LLC. now owns 5,252 shares of the exchange traded fund’s stock valued at $446,000 after purchasing an additional 853 shares during the last quarter. Finally, Texas Yale Capital Corp. raised its holdings in shares of SPDR S&P Biotech by 4.9% during the fourth quarter. Texas Yale Capital Corp. now owns 19,375 shares of the exchange traded fund’s stock valued at $1,644,000 after purchasing an additional 900 shares during the last quarter.

Shares of SPDR S&P Biotech traded down $0.50, reaching $93.28, during mid-day trading on Friday, according to Marketbeat. The stock had a trading volume of 202,797 shares, compared to its average volume of 4,801,770. SPDR S&P Biotech has a 12 month low of $92.15 and a 12 month high of $93.00.



SPDR S&P Biotech Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Institutional Ownership by Quarter for SPDR S&P Biotech (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply